SFTPB and lung carcinoma: Previous studies identified downregulation of SFTPB in mice to be associated with accelerated tumour growth and rate of epithelial-mesenchymal transition38, and higher SFTPB expression in tumour samples is associated with better survival among lung cancer patients37.